Akèy › Leksemi limfoblastik egi › New York › New York City
Etid klinik pou Leksemi limfoblastik egi nan New York City, NY
23 etid pou Leksemi limfoblastik egi ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Ap rekriteEtid obsèvasyon
- Columbia University Medical Center, New York
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Ap rekriteFaz 1/2
- Montefiore Medical Center, New York
Cord Blood Transplant in Adults With Blood Cancers
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of CTD402 in T-ALL/LBL Patients
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Ap rekriteFaz 1/2
- Research Site, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- ak 3 plis
A Study of Revumenib and Mezigdomide in People With Leukemia
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
European Prospective Investigation Into Childhood Cancer
Ap rekriteEtid obsèvasyon
- Columbia University Irving Medical Center, New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- Memorial Sloan Kettering, New York
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Ap rekrite
- Columbia University Medical Center, New York
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Ap rekriteFaz 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Etid Leksemi limfoblastik egi nan lòt vil
- Houston, TX28 etid
- Seattle, WA21 etid
- Baldwin Park, CA21 etid
- Chicago, IL20 etid
- Atlanta, GA19 etid
- Memphis, TN16 etid
- Washington, DC16 etid
- Philadelphia, PA16 etid
- Boston, MA15 etid
- Los Angeles, CA14 etid
- Mountain View, CA13 etid
- Durham, NC13 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.